Misoprostol alone resource hub: Highlighting its safety & effectiveness

New research brief: Barriers to reproductive health services for immigrant women in the United States

Ibis celebrates the first-ever application for an OTC birth control pill in the United States

Announcing new partnership with AMAZE.org in the Africa region

Announcing the launch of Ibis's Africa Region Strategy for 2022-2025

Celebrating 20 years of impact: A visual chronicle of Ibis's history

Home

Evidence, Power, and Change drive our vision:

A just, inclusive world where we all exercise our human right to a pleasurable, safe, and healthy sexual and reproductive life.

#IbisDrivesChange

Recent Publications

March 2023

Travel for later abortion in the USA: Lived experiences, structural contributors, and abortion fund support

March 2023

"The first difficulty is time:" The impact of gestational age limits on reproductive health and justice in the context of cross-border travel for abortion care in Europe

March 2023

The role of VCAT workshops in addressing provider stigma and expanding access to safe abortion services

News & Announcements

October 2022

Ibis responds to FDA’s announcement to postpone advisory committee meeting for over-the-counter birth control pill

August 2022

New partnership will expand access to comprehensive sexuality education resources in Africa

July 2022

New survey reveals difficulties accessing abortion in Indiana, foreshadows worsening harms now that Roe v. Wade is overturned

Copyright © 2023 Ibis Reproductive Health. All rights reserved. Conflict of Interest Policy